From the lab to the leadership team, breakthrough science demands collaboration. To further our mission to eliminate cancer and related diseases, we partner with top-caliber institutions, companies and philanthropic organizations.
As an academic, teaching, research and patient-treatment organization, Fred Hutch works with other institutions worldwide to develop lifesaving, leading-edge therapies. These therapies and the highest-quality care are made available to patients from around the world through our patient-care environment.
We also collaborate with leading technology companies on game-changing data science projects. One such project uses novel patient-engagement tools that employ biosensors and mobile apps, artificial intelligence and computer vision applications in radiology. Another project uses natural-language processing tools to reduce the time it takes to annotate patient records.
The Fred Hutch/University of Washington Cancer Consortium was formed in 2002 to enhance and accelerate cancer research. It combines the strengths of four independent powerhouses: Fred Hutch, University of Washington and Seattle Children’s. The consortium brings together more than 600 faculty with research interests in basic, clinical and public health sciences.
Fred Hutch has a multi-year contract with the National Cancer Institute to operate the nation’s sole Cancer Information Service contact center. The contact center provides free cancer and smoking-cessation information to people in the United States, Puerto Rico, the U.S. Virgin Islands and the U.S. Associated Pacific Territories.
The first comprehensive cancer center in Uganda, the UCI-Fred Hutch Cancer Centre focuses on cutting-edge research, training and clinical care. Jointly built by Fred Hutch and the Uganda Cancer Institute with support from the U.S. Agency for International Development and the government of Uganda, the center features life sciences and biomedical laboratories, training facilities and a clinic that can accommodate 16,000 outpatient visits each year.
Seattle Translational Tumor Research is a multidisciplinary effort involving physicians and scientists from Fred Hutch, UW Medicine and Seatle's Childrens. Its primary goal: to translate laboratory sciences into the most precise, personalized treatment options for patients with solid-tumor cancers, including cancers of the brain, breast, colon, lung and prostate.
In partnership with regional companies in the technology, biomedical and health care industries, the Cascadia Data Alliance works to develop a health research ecosystem that facilitates best practices in data governance, access and management.
We’ve joined forces with our South Lake Union neighbors UW Medicine and the Allen Institute to create the South Lake Union Collaborative, a formal infrastructure for advancing science. By sharing knowledge and resources, we hope the collaborative members can speed discoveries to market and help improve patient care.
This UW Medicine, Fred Hutch and Seattle Children’s collaboration uses genetic or molecular profiling to create precision treatments for patients.
We work with the Allen Institute to chart the immune system using big data and emerging technologies to reveal how immunity goes astray in cancer.